Hims & Hers Health Inc. buy BiotechBee
Start price
11.05.25
/
70%
€47.89
Target price
31.08.27
€100.00
Performance (%)
-10.00%
End price
29.06.25
€43.10
Summary
This prediction ended on 29.06.25 with a price of €43.10. The prediction for Hims & Hers Health Inc. disappointed with a performance of -10.00%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Hims & Hers Health Inc. | -1.962% | -1.962% |
| iShares Core DAX® | -0.121% | 2.507% |
| iShares Nasdaq 100 | 0.081% | -0.241% |
| iShares Nikkei 225® | -1.748% | 4.105% |
| iShares S&P 500 | -0.961% | -0.143% |
According to BiotechBee what are the pros and cons of Hims & Hers Health Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Hims & Hers Health Inc. diskutieren
Buy mit Kursziel 100,0